Tofacitinib market to reach $6.53 billion by 2030 at 14.0% CAGR, driven by increasing number of patients with inflammatory bowel disease.
Read More
Global Oncology Nutrition market size is expected to reach $3.27 billion by 2030 at 9.4%, surge in cancer prevalence drives growth in oncology nutrition market
Read More
Tnf alpha inhibitors market to reach $50.58 billion by 2030 at 3.0% CAGR, driven by increasing geriatric population susceptible to autoimmune disorders.
Read More
Oncology Companion Diagnostics market size is expected to reach $6.5 billion by 2030 at 10.9%, driven by rising cancer cases.
Read More
Tissue regeneration scaffold market to reach $5.58 billion by 2030 at 16.3% CAGR, driven by growing number of trauma cases from accidents and injuries.
Read More
The global oncology based in-vivo cro market to reach $2.54 billion by 2030 at 11.2% cagr, driven by growing prevalence of cancer.
Read More
Tissue plasminogen activator market to reach $5.66 billion by 2030 at 8.6% CAGR, driven by rising prevalence of lifestyle-related disorders.
Read More
Global Oncology Ablation market size is expected to reach $2.61 billion by 2030 at 12.4%, segmented as by radiofrequency ablation, monopolar radiofrequency ablation, bipolar radiofrequency ablation
Read More
Tissue engineering for wound care market to reach $13.61 billion by 2030 at 14.4% CAGR, driven by increasing prevalence of musculoskeletal disorders.
Read More
Global Oncologists market size is expected to reach $25.07 billion by 2030 at 4.4%, growing prevalence of cancer drives the oncologist market
Read More